Literature DB >> 6798225

Pseudomonas aeruginosa bacteriophage phi PLS27-lipopolysaccharide interactions.

K F Jarrell, A M Kropinski.   

Abstract

We investigated the phi PLS27 receptor in Pseudomonas aeruginosa strain PAO lipopolysaccharide (LPS) by analyzing a resistant mutant. This mutant, which was designated AK1282, had the most defective LPS yet reported for a P. aeruginosa rough mutant; this LPS contained only lipid A, 2-keto-3-deoxyoctonate, heptose, and alanine as major components. In addition, this LPS lacked galactosamine, which is present in the inner core of the LPS of other rough mutants. The loss of galactosamine but only a small decrease in the alanine content indicated that the core of strain PAO LPS differed from the core structure which has been suggested for the LPS of other well-characterized P. aeruginosa strains. Our analysis also indicated that galactosamine residues may be crucial for phi PLS27 receptor activity of the LPS. Electrodialysis of LPS and conversion to salt forms (sodium or triethylamine) influenced the phage-inactivating capacity of the LPS, as did the medium in which the inactivation occurred; experiments performed in 1/10-strength broth resulted in much lower PhI50 (concentration of LPS causing a 50% decrease in the titer of phage during 1 h of incubation at 37 degrees C) values than experiments performed in regular-strength broth. Sonication of the LPS also increased the phage-inactivating capacities of the LPS preparations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6798225      PMCID: PMC256642          DOI: 10.1128/JVI.40.2.411-420.1981

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  The assay and characterization of amines by 2,4-dinitrofluorobenzene.

Authors:  D T DUBIN
Journal:  J Biol Chem       Date:  1960-03       Impact factor: 5.157

2.  Non-smooth mutants of Salmonella typhimurium: differentiation by phage sensitivity and genetic mapping.

Authors:  R G Wilkinson; P Gemski; B A Stocker
Journal:  J Gen Microbiol       Date:  1972-05

3.  Role of divalent cations in the action of polymyxin B and EDTA on Pseudomonas aeruginosa.

Authors:  M R Brown; J Melling
Journal:  J Gen Microbiol       Date:  1969-12

4.  Loss of sensitivity to EDTA by Pseudomonas aeruginosa grown under conditions of Mg-limitation.

Authors:  M R Brown; J Melling
Journal:  J Gen Microbiol       Date:  1968-12

5.  Biological activities of chemically modified endotoxins.

Authors:  E T Rietschel; C Galanos; A Tanaka; E Ruschmann; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1971-09-24

6.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

7.  Studies of a receptor for felix O-1 phage in Salmonella minnesota.

Authors:  A A Lindberg
Journal:  J Gen Microbiol       Date:  1967-08

8.  Reaction of endotoxin and surfactants. I. Physical and biological properties of endotoxin treated with sodium deoxycholate.

Authors:  E Ribi; R L Anacker; R Brown; W T Haskins; B Malmgren; K C Milner; J A Rudbach
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

9.  Further studies of the chemical composition of the lipopolysaccharide of Pseudomonas aeruginosa.

Authors:  I R Chester; G W Gray; S G Wilkinson
Journal:  Biochem J       Date:  1972-01       Impact factor: 3.857

10.  The chemical composition of the lipopolyacarideof Pseudomonas aeruginosa.

Authors:  A H Fensom; G W Gray
Journal:  Biochem J       Date:  1969-09       Impact factor: 3.857

View more
  13 in total

1.  Isolation and characterization of two genes, waaC (rfaC) and waaF (rfaF), involved in Pseudomonas aeruginosa serotype O5 inner-core biosynthesis.

Authors:  T R de Kievit; J S Lam
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

2.  O-antigen conversion in Pseudomonas aeruginosa PAO1 by bacteriophage D3.

Authors:  J Kuzio; A M Kropinski
Journal:  J Bacteriol       Date:  1983-07       Impact factor: 3.490

3.  Bacteriophage ecology in Escherichia coli and Pseudomonas aeruginosa mixed-biofilm communities.

Authors:  Matthew K Kay; Thomas C Erwin; Robert J C McLean; Gary M Aron
Journal:  Appl Environ Microbiol       Date:  2010-12-03       Impact factor: 4.792

4.  Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa.

Authors:  S J Cryz; T L Pitt; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

5.  Purification and characterization of phosphomannomutase/phosphoglucomutase from Pseudomonas aeruginosa involved in biosynthesis of both alginate and lipopolysaccharide.

Authors:  R W Ye; N A Zielinski; A M Chakrabarty
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

6.  Molecular cloning of genes involved with expression of A-band lipopolysaccharide, an antigenically conserved form, in Pseudomonas aeruginosa.

Authors:  J Lightfoot; J S Lam
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

7.  Synthesis of lipopolysaccharide O side chains by Pseudomonas aeruginosa PAO1 requires the enzyme phosphomannomutase.

Authors:  J B Goldberg; K Hatano; G B Pier
Journal:  J Bacteriol       Date:  1993-03       Impact factor: 3.490

8.  Antibacterial efficacy of phages against Pseudomonas aeruginosa infections in mice and Drosophila melanogaster.

Authors:  Yun-Jeong Heo; Yu-Rim Lee; Hyun-Hee Jung; JungEun Lee; GwangPyo Ko; You-Hee Cho
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

9.  The Pseudomonas aeruginosa algC gene encodes phosphoglucomutase, required for the synthesis of a complete lipopolysaccharide core.

Authors:  M J Coyne; K S Russell; C L Coyle; J B Goldberg
Journal:  J Bacteriol       Date:  1994-06       Impact factor: 3.490

10.  Characterization of lipopolysaccharide-deficient mutants of Pseudomonas aeruginosa derived from serotypes O3, O5, and O6.

Authors:  T Dasgupta; T R de Kievit; H Masoud; E Altman; J C Richards; I Sadovskaya; D P Speert; J S Lam
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.